BIO · NYSE · Medical - Devices

Bio-Rad Laboratories (BIO)

Supplies droplet digital PCR, clinical-laboratory systems, reagents, controls, and recurring consumables.

$381.45
vs last close+4.12 (+1.09%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue632681611638650667585652653693592651
Cost of revenue296315284283294326279306310348283305
Gross profit336366326355356342306345343345309346
245268274254291284282268278282275273
Research & development446264599180746171666361
Selling, general & administrative201206210196200204209208207217212212
Other expenses000−200000000
Operating income9198521016458247766623473
46331439−2,888797−96760337−498867−724470
Interest income171734171616361514312122
Interest expense12121212121212131212120
Other non-operating income−59−343−4512,876−809955−72−350485−879712−470
Income before tax137428491−2,786862−90983414−431929−690542
Income tax expense3179107−621208−1931996−89209−163171
Net income from continuing operations106350384−2,165653−71664318−342720−527371
Net income106350384−2,165653−71664318−342720−527371
EPS, basic$3.65$12.15$13.46−$76.26$23.37−$25.57$2.29$11.67−$12.70$26.69−$19.55$13.89
EPS, diluted$3.64$12.14$13.45−$76.26$23.34−$25.57$2.29$11.67−$12.70$26.65−$19.55$13.85
Weighted average shares, basic292929282828282727272727
Weighted average shares, diluted292929282828282727272727
EBITDA198494551−2,727923−847134477−365994−637542
Depreciation & amortization48534847494938515452410
EBIT150441503−2,774874−89795427−419941−678542